SM
Sean A. McCarthy (CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in CytomX Therapeutics, Inc. (CTMX). The largest single filing was $764K of CTMX (118,969 sh × $6.42, as filed), executed Mar 17. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Mar 17
Filed Mar 19
Median ADV $7.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CTMXRecent filings
CTMXSALE
CytomX Therapeutics, Inc.
View filing →
$764K118,969 sh × $6.42
Exec Mar 17
Filed Mar 19 · 5:30 PM ET CTMXSALE CytomX Therapeutics, Inc. View filing → $462K
101,793 sh × $4.54
Exec Nov 6 2025
Filed Oct 16 · 7:40 PM ET † CTMXSALE CytomX Therapeutics, Inc. View filing → $462K
101,793 sh × $4.54
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET CTMXSALE CytomX Therapeutics, Inc. View filing → $149K
55,511 sh × $2.69
Exec Jun 16 2025
Filed Jun 17 2025 · 5:30 PM ET